Peripheral Arterial Disease Market is segmented By Treatment (Drug Therapy, Endovascular Therapy), B...
Market Size in USD Bn
CAGR7.00%
Study Period | 2025-2032 |
Base Year of Estimation | 2024 |
CAGR | 7.00% |
Market Concentration | High |
Major Players | Novartis, Bayer, Pfizer, Amgen, Sanof and Among Others |
The peripheral arterial disease market is estimated to be valued at USD 5.14 Bn in 2025 and is expected to reach USD 8.25 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.00% from 2025 to 2032. The increasing prevalence of diabetes, obesity, and hypertension are major factors driving the growth of the peripheral arterial disease market.